Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06212193 · ClinicalTrials.gov registry record · NA
Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)
A NA study of Tricuspid Regurgitation and Tricuspid Regurgitation Functional, sponsored by Innoventric.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 12
- Study locations
NCT06212193 is a NA study of Tricuspid Regurgitation and Tricuspid Regurgitation Functional that is actively recruiting participants, run by Innoventric. The registered enrollment target is 15 participants, below the 535-participant average among 17 other Tricuspid Regurgitation trials with a reported enrollment target (97% lower). The trial reports 12 study locations across 11 states.
The verdict
NCT06212193, a NA study of Tricuspid Regurgitation and Tricuspid Regurgitation Functional, is actively recruiting participants, sponsored by Innoventric.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 12
- Study locations
Study Summary
Early Feasibility Study to evaluate the safety and performance of the Innoventric Trillium™ Stent Graft in the treatment of severe or greater tricuspid regurgitation (TR).
Conditions Studied
Interventions
- DEVICE Trillium™
Study Locations (12)
New York
- Weill Cornell Medicine - New York
- Stony Brook Heart Institute - Stony Brook
California
- Cardiovascular Institute of Los Robles Health System - Thousand Oaks
Michigan
- Ascension St. John - Detroit
Minnesota
- Mayo Clinic Hospital (Rochester) - Rochester
Ohio
- The Christ Hospital - Cincinnati
Pennsylvania
- Lankenau Heart Institute - Philadelphia
Tennessee
- TriStar Centennial Medical Center - Nashville
Washington
- University of Washington Medical Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2024-08-05 |
| Est. Completion | 2030-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06212193
The ClinicalTrials.gov registry entry for NCT06212193 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 535-participant average among 17 other Tricuspid Regurgitation trials with a reported enrollment target (97% lower). The listed sponsor is Innoventric, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Tricuspid Regurgitation appearing as the primary indexed condition, and to 1 intervention - of which Trillium™ is the first listed.
NCT06212193 reports 12 study locations spanning 11 distinct geographic areas - top geographies include New York, California, Michigan.
Frequently Asked Questions
What is clinical trial NCT06212193 about?
NCT06212193 is a clinical study titled "Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)". Early Feasibility Study to evaluate the safety and performance of the Innoventric Trillium™ Stent Graft in the treatment of severe or greater tricuspid regurgitation (TR).
What is the current status of trial NCT06212193?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2024-08-05. Estimated completion is 2030-08.
What conditions does trial NCT06212193 study?
This clinical trial studies the following conditions: Tricuspid Regurgitation, Tricuspid Regurgitation Functional.
What interventions are being tested in trial NCT06212193?
The interventions under investigation include: Trillium™ (DEVICE).
Who is sponsoring clinical trial NCT06212193?
This trial is sponsored by Innoventric, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06212193 being conducted?
This trial has 12 study locations across California, Michigan, Minnesota, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tricuspid Regurgitation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TTVR Early Feasibility Study
RECRUITING · NA
-
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)
RECRUITING · NA
-
Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
RECRUITING · NA
-
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
RECRUITING · NA
-
Trisol System EFS Study
RECRUITING · NA
-
EFS of the DUO System for Tricuspid Regurgitation
RECRUITING · NA
Explore more on PlainTrial
Tricuspid Regurgitation
All registered trials for this condition
Tricuspid Regurgitation Functional
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.